Edwards Lifesciences Corp (EW: NYSE)
$151.35 -4.45 | -2.86%
07/29/15 - 11:56 AM ET
Portfolios with EW
- Portfolio NameUser Type
- ProAl Gore - Generation Invest...
- ContributorTechnical Setups for the We...
- Contributor10 Best-Performing S&P 500 ...
- ContributorRelative Strength Trades fo...
- UserThe Coming M&A boom
- Contributor3 Large-Cap Stocks Insiders...
- Contributor8 Health Care Stocks Inside...
- Contributor5 Stocks JPMorgan Warns to ...
- UserFive Star All Cap Fund
- Contributor6 Health Care Stocks to Gai...
Latest EW Headlines from TheStreet
- Edwards Lifesciences (EW) Falls Further As It's Water-Logged And Getting Wetter 07.29.15 | 11:07 am
- Edwards Lifesciences (EW) Earnings Report: Q2 2015 Conference Call Transcript 07.29.15 | 09:07 am
- Edwards Lifesciences Moves Up In Analyst Rankings, Passing Micron Technology 07.28.15 | 11:07 am
- Cramer Sees T-Mobile Pricing Impacts; Doesn't Recommends Gold ETFs 07.21.15 | 02:07 pm
- Trade-Ideas: Edwards Lifesciences (EW) is Today's Post-Market Leader Stock 07.16.15 | 04:07 pm
- Trade-Ideas: Edwards Lifesciences (EW) Is Today's Unusual Social Activity Stock 07.13.15 | 10:07 am
- Edwards Lifesciences (EW) Stock Upgraded at RBC 07.13.15 | 09:07 am
- 3 Stocks Boosting The Health Care Sector Higher 07.06.15 | 01:07 pm
- Jim Cramer's 'Mad Money' Recap: We're Not Out of the Woods Yet 07.01.15 | 07:07 pm
- Edwards Lifesciences (EW) Stock Upgraded at BMO Capital Markets 06.09.15 | 09:06 am
Press Releases for EW
- Edwards Lifesciences To Host Earnings Conference Call On July 28, 2015 - PR Newswire 07.14.15 | 10:07 am
- Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ - PR Newswire 07.10.15 | 05:07 pm
- Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve - PR Newswire 06.17.15 | 07:06 pm
- Edwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor - PR Newswire 06.08.15 | 06:06 am
- Edwards Lifesciences To Present At Goldman Sachs 36th Annual Global Healthcare Conference - PR Newswire 06.03.15 | 04:06 pm
- SAPIEN 3 Valve Again Demonstrates Low Mortality, Excellent 30-Day Outcomes In Intermediate-Risk Patients - PR Newswire 05.20.15 | 04:05 am
- Edwards Pauses Enrollment In Early Stage Mitral Program - PR Newswire 05.19.15 | 09:05 am
- First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate - PR Newswire 05.19.15 | 08:05 am
- Edwards Lifesciences To Webcast Annual Meeting Of Stockholders - PR Newswire 05.07.15 | 10:05 am
- Edwards Lifesciences To Host Earnings Conference Call On April 23, 2015 - PR Newswire 04.10.15 | 08:04 am
Partner Headlines for EW
- Edwards Lifesciences price target raised to $179 from $157 at Stifel - The Fly 07.29.15 | 07:07 am
- Edwards Lifesciences price target raised to $178 from $160 at Canaccord - The Fly 07.29.15 | 07:07 am
- Edwards Lifesciences price target raised to $185 from $155 at Leerink - The Fly 07.29.15 | 07:07 am
- Edwards Lifesciences price target raised to $168 from $155 at JPMorgan - The Fly 07.29.15 | 07:07 am
- Heart Valve Quickens Interest In Edwards Lifesciences - Investor's Business Daily 07.14.15 | 05:07 pm
- Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant - Investor's Business Daily 07.13.15 | 06:07 pm
- Stocks Hold Gains; Edwards Lifesciences Breaks Out On Upgrade - Investor's Business Daily 07.13.15 | 12:07 pm
- Edwards Lifesciences upgraded to Outperform from Market Perform at Northland - The Fly 07.13.15 | 08:07 am
- Canaccord recommends Edwards Lifesciences, Neovasc in TMVR sector - The Fly 07.13.15 | 07:07 am
- Edwards Lifesciences upgraded to Outperform from Sector Perform at RBC Capital - The Fly 07.13.15 | 07:07 am